Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.Acta Neuropathologica Communications|June 9, 2018
The genetic landscape of gangliogliomaMelike Pekmezci, Javier E Villanueva-Meyer, Benjamin Goode, et al.Pediatric Blood & Cancer|June 14, 2021
Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinomaRichard T Graham, Mohammad H Abu-Arja, Joseph R Stanek, et al.Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.Brain Pathology (Zurich, Switzerland)|October 15, 2019
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic featuresCalixto-Hope G Lucas, Javier E Villanueva-Meyer, Nicholas Whipple, et al.Cell Reports. Medicine|May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressureJenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.Pageof 2